Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19
Main Author: | Michael R. Yeaman |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-08-01
|
Series: | Glomerular Diseases |
Online Access: | https://www.karger.com/Article/FullText/519182 |
Similar Items
-
Implications of COVID-19 (SARS-CoV-2) for the anesthesiological practice
by: Gabriel Enrique Mejía-Terrazas, et al.
Published: (2020-07-01) -
SARS-CoV-2 and Cancer: Beyond Immunosuppression
by: Diogo Mendes Pedro, et al.
Published: (2021-03-01) -
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
by: Carmen Elena Gómez, et al.
Published: (2021-03-01) -
SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
by: Vincenzo Baldo, et al.
Published: (2021-01-01) -
Proposed therapies and vaccine developing for COVID-19 (SARS CoV-2)
by: Gamal, Abdelaziz, et al.
Published: (2020-06-01)